These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 15981676)

  • 21. Decreased myocardial 123I-MIBG uptake in Parkinson's disease.
    Iwasa K; Nakajima K; Yoshikawa H; Tada A; Taki J; Takamori M
    Acta Neurol Scand; 1998 May; 97(5):303-6. PubMed ID: 9613559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [123 I-MIBG myocardial sympathetic innervation scintigraphy and Parkinson's disease. Preliminary results].
    Jiménez-Hoyuela JM; Rebollo AC; Campos V; Rius F
    Rev Esp Med Nucl; 2003; 22(4):229-37. PubMed ID: 12846947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 1-23I-MIBG thyroid uptake: Implications for MIBG imaging of the heart.
    Giubbini R; Milan E; Marcassa C; Paghera B; Fracassi F; Camoni L; Rodella C; Bertagna F; Motta F; Bertoli M; Campini R
    J Nucl Cardiol; 2016 Dec; 23(6):1335-1339. PubMed ID: 25963285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differentiation of Parkinson's disease and multiple system atrophy in early disease stages by means of I-123-MIBG-SPECT.
    Druschky A; Hilz MJ; Platsch G; Radespiel-Tröger M; Druschky K; Kuwert T; Neundörfer B
    J Neurol Sci; 2000 Apr; 175(1):3-12. PubMed ID: 10785250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiac uptake of [123I]MIBG separates PD from multiple system atrophy.
    Yoshita M
    Neurology; 2000 May; 54(9):1877-8. PubMed ID: 10802810
    [No Abstract]   [Full Text] [Related]  

  • 26. Diagnostic accuracy of apparent diffusion coefficient and 123I-metaiodobenzylguanidine for differentiation of multiple system atrophy and Parkinson's disease.
    Umemura A; Oeda T; Hayashi R; Tomita S; Kohsaka M; Yamamoto K; Sawada H
    PLoS One; 2013; 8(4):e61066. PubMed ID: 23613784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cardiac sympathetic dysfunction in Parkinson's disease--relationship between results of 123I-MIBG scintigraphy and autonomic nervous function evaluated by the Valsalva maneuver].
    Oka H; Yoshioka M; Morita M; Mochio S; Inoue K
    Rinsho Shinkeigaku; 2003 Aug; 43(8):465-9. PubMed ID: 14658397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MIBG scintigraphy for differentiating Parkinson's disease with autonomic dysfunction from Parkinsonism-predominant multiple system atrophy.
    Chung EJ; Lee WY; Yoon WT; Kim BJ; Lee GH
    Mov Disord; 2009 Aug; 24(11):1650-5. PubMed ID: 19514077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic Value of the Early Heart-to-Mediastinum Count Ratio in Cardiac 123I-mIBG Imaging for Parkinson's Disease.
    Frantellizzi V; Lavelli V; Ferrari C; Sardaro A; Farcomeni A; Pacilio M; Borrazzo C; Pani R; Rubini G; Vincentis G
    Curr Radiopharm; 2021; 14(1):64-69. PubMed ID: 32720610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac sympathetic denervation and dementia in de novo Parkinson's disease: A 7-year follow-up study.
    Choi MH; Yoon JH; Yong SW
    J Neurol Sci; 2017 Oct; 381():291-295. PubMed ID: 28991700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impaired cardiac uptake of meta-[123I]iodobenzylguanidine in Parkinson's disease with autonomic failure.
    Braune S; Reinhardt M; Bathmann J; Krause T; Lehmann M; Lücking CH
    Acta Neurol Scand; 1998 May; 97(5):307-14. PubMed ID: 9613560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical and pathological study on early diagnosis of Parkinson's disease and dementia with Lewy bodies].
    Orimo S
    Rinsho Shinkeigaku; 2008 Jan; 48(1):11-24. PubMed ID: 18386627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 123I-metaiodobenzylguanidine scintigraphy in Parkinson's disease and related disorders.
    Rascol O; Schelosky L
    Mov Disord; 2009; 24 Suppl 2():S732-41. PubMed ID: 19877202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impaired myocardial 123I-metaiodobenzylguanidine uptake in Lewy body disease: comparison between dementia with Lewy bodies and Parkinson's disease.
    Suzuki M; Kurita A; Hashimoto M; Fukumitsu N; Abo M; Ito Y; Urashima M; Inoue K
    J Neurol Sci; 2006 Jan; 240(1-2):15-9. PubMed ID: 16199056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural changes in Parkinson's disease: voxel-based morphometry and diffusion tensor imaging analyses based on
    Kikuchi K; Hiwatashi A; Togao O; Yamashita K; Somehara R; Kamei R; Baba S; Yamaguchi H; Kira JI; Honda H
    Eur Radiol; 2017 Dec; 27(12):5073-5079. PubMed ID: 28677058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent developments in innervation imaging using iodine-123-metaiodobenzylguanidine scintigraphy in Lewy body diseases.
    Treglia G; Cason E; Gabellini A; Giordano A; Fagioli G
    Neurol Sci; 2010 Aug; 31(4):417-22. PubMed ID: 20221656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Usefulness of 5 Minutes
    Frantellizzi V; Ricci M; Farcomeni A; Pontico M; Pani A; Vincentis G
    Curr Radiopharm; 2020; 13(2):120-129. PubMed ID: 31985388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of thyroid blockade on thyroid radioiodine uptake in 123I-mIBG imaging.
    Friedman NC; Hassan A; Grady E; Matsuoka DT; Jacobson AF
    J Nucl Med; 2014 Feb; 55(2):211-5. PubMed ID: 24385600
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Striatal dopamine activity and myocardial
    Oh YS; Kim JS; Yoo SW; Hwang EJ; Lyoo CH; Lee KS
    Parkinsonism Relat Disord; 2019 Jun; 63():156-161. PubMed ID: 30796009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differentiating Parkinson disease from multiple-system atrophy by measuring cardiac iodine-123 metaiodobenzylguanidine accumulation.
    Takatsu H; Nagashima K; Murase M; Fujiwara H; Nishida H; Matsuo H; Watanabe S; Satomi K
    JAMA; 2000 Jul; 284(1):44-5. PubMed ID: 10872011
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.